Cite
MLA Citation
Deniz Tataroglu Ozyukseler et al.. “Prognostic factors of ado-trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer.” Journal of oncology pharmacy practice, vol. 27, 2021, pp. 547–554. http://access.bl.uk/ark:/81055/vdc_100118236460.0x00000c